A drug compound for treating cholangiocarcinoma and its application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV
- Publication Date
- 2021-07-20
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of pharmaceutical compositions, in particular to a pharmaceutical compound for treating cholangiocarcinoma and its application. Background technique
[0002] Cholangiocarcinoma is the second most common malignant tumor of the hepatobiliary system after hepatocellular carcinoma. According to statistics, the overall mortality rate of hepatobiliary malignancies ranks fifth among all malignancies. my country is an area with a high incidence of cholangiocarcinoma, and the incidence has been increasing in recent years. It is more aggressive than hepatocellular carcinoma, only 30%-40% of patients can be effectively treated by surgical resection at the time of diagnosis, and most of the patients are already at an advanced stage when they are diagnosed, lacking effective treatment methods, and the prognosis is extremely poor Difference. Therefore, it is urgent to find new and effective treatment options.
[0003] Levamisol...